Latest Conference Articles

Educated Patient® Skin Cancer Summit Basal Cell Carcinoma/Squamous Cell Carcinoma Presentation: June 18, 2022

Educated Patient® Skin Cancer Summit Basal Cell Carcinoma/Squamous Cell Carcinoma Presentation: June 18, 2022

July 6th 2022, 1:00pm

Educated Patient® Skin Cancer Summit: June 18, 2022

Watch Dr. Barbara Ma, from Weill Cornell Medicine, discuss the basics of basal and squamous cell carcinomas during the CURE Educated Patient Skin Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Outside of Treatment Panel: June 11, 2022

Educated Patient® Metastatic Breast Cancer Summit Outside of Treatment Panel: June 11, 2022

July 5th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Emily Huskey, Dr. Wendy Baer, Fabienne Ehivet and Lisa Weems answer questions about areas outside of treatment during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Genetic Testing Presentation: June 11, 2022

Educated Patient® Metastatic Breast Cancer Summit Genetic Testing Presentation: June 11, 2022

July 4th 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Fabienne Ehivet, from Emory Saint Joseph’s Hospital, discuss genetic testing, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Addressing Psychosocial Issues Presentation: June 11, 2022

Educated Patient® Metastatic Breast Cancer Summit Addressing Psychosocial Issues Presentation: June 11, 2022

July 3rd 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Wendy Baer, from Winship Cancer Institute at Emory University, discuss psychosocial issues, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Diet & Exercise Presentation: June 11, 2022

Educated Patient® Metastatic Breast Cancer Summit Diet & Exercise Presentation: June 11, 2022

July 2nd 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Emily Huskey, from the Winship Cancer Institute of Emory University, discuss diet and exercise, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Additional Care Panel: June 11, 2022

Educated Patient® Metastatic Breast Cancer Summit Additional Care Panel: June 11, 2022

July 1st 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Kimberly Curseen, Dr. Anna Bausum, Dr. Kevin Kalinsky and Alyncia Mason answer questions about additional care, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Clinical Trials Presentation: June 11, 2022

Educated Patient® Metastatic Breast Cancer Summit Clinical Trials Presentation: June 11, 2022

June 30th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Kevin Kalinsky, from Winship Cancer Institute of Emory University, discuss joining clinical trials, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Integrating Alternative Medicine Presentation: June 11, 2022

Educated Patient® Metastatic Breast Cancer Summit Integrating Alternative Medicine Presentation: June 11, 2022

June 29th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Anna Bausum, Winship Cancer Institute at Emroy University, discuss alternative medicine, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Supportive Care Presentation: June 11, 2022

Educated Patient® Metastatic Breast Cancer Summit Supportive Care Presentation: June 11, 2022

June 28th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Kimberly Curseen, from Winship Cancer Institute of Emory University, discuss supportive care, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Updates in Disease Management Panel: June 11, 2022

Educated Patient® Metastatic Breast Cancer Summit Updates in Disease Management Panel: June 11, 2022

June 27th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Suchita Pakkala, Dr. Jane Meisel, Dr. Keerthi Gogineni and Kelly Shanahan discuss updates in disease management during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Estrogen Receptor-Positive Presentation: June 11, 2022

Educated Patient® Metastatic Breast Cancer Summit Estrogen Receptor-Positive Presentation: June 11, 2022

June 24th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Suchita Pakkala, from Emory University School of Medicine, discuss estrogen receptor-positive disease, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Prostate Cancer Summit Looking Ahead Panel: May 21, 2022

Educated Patient® Prostate Cancer Summit Looking Ahead Panel: May 21, 2022

June 17th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Jeremie Calais, Dr. Tian Zhang, Dr. Landon C. Brown and Jim Rosenfield answer questions about novel agents and strategies during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Approaches to Hormone Therapy Presentation: May 21, 2022

Educated Patient® Prostate Cancer Summit Approaches to Hormone Therapy Presentation: May 21, 2022

June 16th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Landon C. Brown, from Atrium Health Levine Cancer Institute, discuss approaches to hormone therapy, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Novel Agents Presentation: May 21, 2022

Educated Patient® Prostate Cancer Summit Novel Agents Presentation: May 21, 2022

June 15th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Tian Zhang, from UT Southwestern Medical Center, discuss novel agents, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Novel Imaging Strategies Presentation: May 21, 2022

Educated Patient® Prostate Cancer Summit Novel Imaging Strategies Presentation: May 21, 2022

June 14th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Jeremie Calais, from UCLA, discuss novel imaging strategies, during the CURE Educated Patient Prostate Cancer Summit.

Time-Limited Venclexta Regimens Outperform Chemoimmunotherapy in CLL

Time-Limited Venclexta Regimens Outperform Chemoimmunotherapy in CLL

June 13th 2022, 9:00pm

Treatment with Venclexta plus Gazyva, with or without Imbruvica, led to better outcomes than chemoimmunotherapy in patients with chronic lymphocytic leukemia.

Educated Patient® Prostate Cancer Summit Genetics & Genomics Panel: May 21, 2022

Educated Patient® Prostate Cancer Summit Genetics & Genomics Panel: May 21, 2022

June 13th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Veda N. Giri, Dr. Umang Swami and Sue Friedman answer questions about genetics and genomics during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Genomics Presentation: May 21, 2022

Educated Patient® Prostate Cancer Summit Genomics Presentation: May 21, 2022

June 12th 2022, 2:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Umang Swami, from Huntsman Cancer Institute, discuss genomic changes and PARP inhibitors, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Genetic Testing Presentation: May 21, 2022

Educated Patient® Prostate Cancer Summit Genetic Testing Presentation: May 21, 2022

June 11th 2022, 2:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Veda N. Giri, from Sidney Kimmel Cancer Center at Thomas Jefferson University, discuss genetic testing and who should get it, during the CURE Educated Patient Prostate Cancer Summit.

Brukinsa Continues to Outperform Imbruvica for MYD88-Mutant Waldenström Macroglobulinemia

Brukinsa Continues to Outperform Imbruvica for MYD88-Mutant Waldenström Macroglobulinemia

June 10th 2022, 9:00pm

ASCO Annual Meeting

Brukinsa, which was approved in September 2021, resulted in better ouctomes for certain patients with with Waldenström macroglobulinemia, according to the ASPEN clinical trial.

Addition of Stem Cell Transplant Boosts Outcomes for Common Myeloma Regimen

Addition of Stem Cell Transplant Boosts Outcomes for Common Myeloma Regimen

June 10th 2022, 7:00pm

ASCO Annual Meeting

Patients who underwent Revlimid, Velcade, and dexamethasone therapy followed by maintenance Revlimid, tended to have better outcomes when they underwent autologous stem cell transplant.

Educated Patient® Prostate Cancer Summit Treatment in Localized Disease Panel: May 21, 2022

Educated Patient® Prostate Cancer Summit Treatment in Localized Disease Panel: May 21, 2022

June 10th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Ganesh Raj, Dr. Andrew Z. Wang, and Bruce Williams, discuss treatment for localized disease, during the CURE Educated Patient Prostate Cancer Summit.

Pre- and Post-Surgical Jakafi Plus Chemo Shows Potential in Advanced Ovarian Cancer

Pre- and Post-Surgical Jakafi Plus Chemo Shows Potential in Advanced Ovarian Cancer

June 9th 2022, 7:00pm

The use of Jakafi plus chemotherapy shows promise in the pre- and post-surgical treatment settings for patients with stage 3 and 4 ovarian cancer, warranting further study of the combination.

Keytruda Demonstrates Significant Improvement for Some Patients with Melanoma

Keytruda Demonstrates Significant Improvement for Some Patients with Melanoma

June 9th 2022, 3:00pm

ASCO Annual Meeting

Keytruda, an immunotherapy agent, demonstrated significant improvement in both distant metastasis-free survival and recurrence-free survival compared to placebo.

Educated Patient® Prostate Cancer Summit Approaches to Radiation Presentation: May 21, 2022

Educated Patient® Prostate Cancer Summit Approaches to Radiation Presentation: May 21, 2022

June 9th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Andrew Z. Wang, from UT Southwestern Medical Center, discuss approaches to radiation for local disease, during the CURE Educated Patient Prostate Cancer Summit.

Durable Responses Continue with Keytruda Plus Chemoradiation in Previously Untreated Non-Small Cell Lung Cancer

Durable Responses Continue with Keytruda Plus Chemoradiation in Previously Untreated Non-Small Cell Lung Cancer

June 8th 2022, 9:00pm

After more than two years of follow-up, patients with previously untreated, locally advanced stage 3 non–small cell lung cancer continue to derive a benefit from treatment with Keytruda and chemoradiation.

Jemperli Eliminated All Signs of Rectal Cancer in Small Clinical Trial, Warranting Further Research

Jemperli Eliminated All Signs of Rectal Cancer in Small Clinical Trial, Warranting Further Research

June 8th 2022, 7:00pm

ASCO Annual Meeting

One-hundred percent of patients with stage 2/3 mismatch repair-deficient rectal cancer had their disease disappear after treatment with Jermperli, though more research and longer follow-up is needed.

Exkivity Delivers Minimal Benefit to Patients with Non-Small Cell Lung Cancer and Brain Metastases

Exkivity Delivers Minimal Benefit to Patients with Non-Small Cell Lung Cancer and Brain Metastases

June 8th 2022, 3:00pm

ASCO Annual Meeting

Although ineffective in patients with non-small cell lung cancer and brain metastases at diagnosis, treatment with Exkivity may benefit patients with EGFR exon 20 insertion-positive metastatic disease.

Educated Patient® Prostate Cancer Summit Overview of Surgery Presentation: May 21, 2022

Educated Patient® Prostate Cancer Summit Overview of Surgery Presentation: May 21, 2022

June 8th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Ganesh V. Raj, from UT Southwestern Medical Center, discuss surgery for localized disease, during the CURE Educated Patient Prostate Cancer Summit.

Ifosfamide Induces ‘Subtle’ Survival Improvement Over Hycamtin-Cyclophosphamide Combo in Ewing Sarcoma

Ifosfamide Induces ‘Subtle’ Survival Improvement Over Hycamtin-Cyclophosphamide Combo in Ewing Sarcoma

June 7th 2022, 9:00pm

The use of the chemotherapy ifosfamide was associated with small improvements in survival outcomes in a group of patients with relapsed/refractory Ewing sarcoma, a rare type of bone or soft tissue cancer.